In this article

Ivím advertises six-month medication offers alongside a separate monthly care membership. Comparing only the drug’s monthly equivalent leaves out part of the program cost and can hide the amount committed to a longer term.

An alternative may use a single bundled payment, a shorter package, or another membership model. This guide compares those arrangements while asking which clinical and coaching services you would gain, keep, or give up.

THE SHORT ANSWER

Add membership to the full medication commitment and compare the support included over the same period. CoreAge Rx holds the first sponsored position; that does not establish that it best meets every criterion.

What to know first

  • Add membership to the full medication commitment and compare the support included over the same period.
  • CoreAge Rx is the first listing through a disclosed commercial arrangement.
  • Confirm the proposed product, care arrangement, and complete written payment terms.

How this shortlist was selected

CoreAge Rx is number one because it is our featured commercial partner. That position is predetermined by our commercial relationship, and we may earn compensation through its links. Other entries illustrate relevant care and payment models; their order is not a ranking of medication quality, safety, or patient outcomes.

Add membership to the full medication commitment and compare the support included over the same period. We used the provider documents linked beside each entry, checked September 21, 2026. We did not purchase treatment, test private accounts, audit every license, or measure response times. The product and current written quote for your own care still need confirmation. Read our review method.

01. CoreAge Rx — featured partner

Our sponsored no-separate-membership comparison. Its full selected-term price and confirmed care services should be compared with Ivím’s combined total.

The current sale page advertises semaglutide from $99 per month and tirzepatide from $149 per month, with no membership fee. Those are advertised starting figures, not a personalized checkout quote. The plan length and total amount due must be read alongside the monthly equivalent.

The sale page says CoreAge works with U.S. compounding pharmacies and describes 503A facilities. A category of pharmacy is not a substitute for the name, address, and state license of the pharmacy filling your own prescription. Request that information before deciding.

Continue with our CoreAge Rx review and pricing details.

02. Mochi Health

Another membership-plus-medication model with dose-based drug pricing. Use the ongoing care fee and the prescribed medication tier.

Mochi advertises a $39 first membership month for eligible new subscribers and a $79 ongoing monthly membership. Its August 2026 pricing explanation describes dose-based compounded semaglutide prices of $60–$99 and tirzepatide prices of $90–$199, with medication billed separately.

Mochi’s pricing article says its transition to dose-based prices did not change the pharmacies or additives for the plans discussed. It does not identify your personal dispensing pharmacy. Confirm the pharmacy and complete formulation shown in your own care plan.

Continue with our Mochi Health review and pricing details.

03. Yucca Health

Publishes monthly and six-month medication options without a membership fee. Compare the full six-month amount and the clinical access actually included.

Yucca lists semaglutide at $125 per month on a six-month plan totaling $750, or $146 month to month. Tirzepatide is listed at $225 per month on a six-month plan totaling $1,350, or $258 month to month.

The $125 headline is a prepaid-plan equivalent, not the monthly-plan charge. Keep the selected term, renewal price, and cancellation policy with the purchase summary.

Check the official Yucca Health program page for the current offer and conditions. Our Yucca Health alternatives comparison examines other care models.

04. Fifty 410

A shorter-package comparison with tiered tirzepatide offers and a monthly semaglutide option. Confirm the selected product and next refill terms.

Fifty 410 lists a three-month compounded tirzepatide starter package at $399 total, displayed as $133 per month. The listed mid- and higher-dose packages are $499 and $549 total. Its semaglutide monthly option is $199. These are different products and package sizes.

Ask which package matches the proposed prescription and whether a returning patient qualifies for a starter offer. A three-month supply and monthly billing are separate arrangements.

Check the official Fifty 410 program page for the current offer and conditions. Our Fifty 410 alternatives comparison examines other care models.

05. Brello Health

Combines medication plans with classes and an app. Its minimum term and 11-week renewal need careful comparison with a six-month medication offer.

Brello displays semaglutide at $133 and tirzepatide at $166 per month as three-month-plan equivalents. Its terms on the same page require a three-month minimum and describe automatic renewal every 11 weeks at the rate shown at checkout.

Read the renewal date as well as the minimum term. The FAQ describes a possible $50 professional-services deduction for qualifying cancellation requests made within 24 hours of the completed provider review; this is not an unconditional refund promise.

Check the official Brello Health program page for the current offer and conditions. Our Brello Health alternatives comparison examines other care models.

06. Shapely

A comparison when recurring provider and dietitian contact matters more than bundled extras. Add the medicine and possible testing charges to membership.

Shapely lists a $49 first self-pay membership month followed by $99 per month. Medication is excluded, and the site separately lists medication starting prices and possible lab charges. Its insured pathway requires an individual coverage check.

Confirm which visits your plan covers and which services belong to the selected membership. Acceptance of an insurance plan does not establish coverage of a weight-loss prescription.

Check the official Shapely program page for the current offer and conditions. Our Shapely alternatives comparison examines other care models.

The current Ivím Health baseline

Ivím’s homepage advertises six months of compounded semaglutide at a $75 monthly equivalent and tirzepatide at a $133 monthly equivalent. It separately lists membership at $75 per month with the first month free. Confirm that those terms apply to the same offer and your state.

Ivím Health describes a membership-supported care model with medication programs, provider access, and coaching. Its homepage advertises six-month compounded GLP-1 offers alongside a separate membership. The medication program and membership deserve separate attention.

Ivím’s terms describe an individualized compounded GLP-1 program with check-ins and clinical oversight. Confirm the actual pharmacy, formulation, refill timing, and any plan expiration rather than assuming a six-month purchase means six identical vials delivered at once.

The details that decide this comparison

Confirm that the displayed medication offer and membership promotion apply together to your prescription and state. Do not combine unrelated offers into a quote.

With the advertised semaglutide and membership terms unchanged, six medication months plus five paid membership months would total $825. This is a budgeting example, not a checkout guarantee.

Ask which coaching, clinician access, and other services belong to the membership and whether they remain available throughout a prepaid medication term.

Keep the treatment distinction clear

An FDA-approved branded medicine and a compounded preparation have different regulatory status. Compounded drugs are not FDA-approved. Trials of an approved product do not prove that every compounded version has the same performance.

Ask the prescribing professional why the exact product is appropriate for you, and identify the dispensing pharmacy. A price, a website’s appearance, or a place in this list cannot establish personal suitability. Our guide to compounded drugs and FDA approval explains the distinction.

Before you make a change

Ask whether cancelling membership affects access to care for medication already paid for, and whether any separate medication order continues. These should be answered as distinct questions.

If published program outcomes influenced your choice, read the study design and product details. Observational results do not prove that every formulation or individual patient will have the same outcome.

Sources & research notes

Checked September 21, 2026. Provider pages document the provider’s own statements; they do not independently establish treatment safety or results. This is desk research, not a product test or clinical review.

  1. CoreAge Rx: official treatment overviewProvider-published information · Checked September 21, 2026
  2. CoreAge Rx: current sale offerProvider-published information · Checked September 21, 2026
  3. CoreAge Rx: plan billing explainedProvider-published information · Checked September 21, 2026
  4. CoreAge Rx: contact and professional-entity disclosuresProvider-published information · Checked September 21, 2026
  5. CoreAge Rx: purchasing processProvider-published information · Checked September 21, 2026
  6. Online Medical Weight Loss Program | Mochi HealthProvider-published information · Checked September 21, 2026
  7. Mochi: August 2026 dose-based pricingProvider-published information · Checked September 21, 2026
  8. Contact us | Mochi HealthProvider-published information · Checked September 21, 2026
  9. Yucca Health: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  10. Fifty 410: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  11. Brello Health: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  12. Shapely: official program, pricing, and care detailsProvider-published information · Checked September 21, 2026
  13. Ivím Health – Individualized Health & Wellness ProgramsProvider-published information · Checked September 21, 2026
  14. Terms and Conditions – Ivím HealthProvider-published information · Checked September 21, 2026
  15. Ivím Health: refill process and support contactsProvider-published information · Checked September 21, 2026
  16. FDA: concerns with unapproved GLP-1 drugsRegulatory / public agency · Checked September 21, 2026
  17. FDA: risks of compounded drugsRegulatory / public agency · Checked September 21, 2026

Read our methodology · Commercial disclosure · Request a correction